BeyondSpring Inc.
(NASDAQ : BYSI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
0.49%35.810.8%$770.50m
JNJJohnson & Johnson
-0.12%124.090.6%$763.30m
ABBVAbbVie, Inc.
0.74%106.772.1%$726.30m
MRKMerck & Co., Inc.
-1.01%58.550.6%$604.37m
BMYBristol-Myers Squibb Company
-0.19%52.611.4%$504.16m
LLYEli Lilly and Company
0.01%82.081.0%$360.88m
AZNAstraZeneca PLC Sponsored ADR
1.34%36.821.3%$155.49m
NVSNovartis AG Sponsored ADR
0.01%77.070.2%$134.97m
GSKGlaxoSmithKline plc Sponsored ADR
0.20%40.110.2%$111.46m
NVONovo Nordisk A/S Sponsored ADR Class B
0.34%48.890.1%$80.64m
SNYSanofi Sponsored ADR
-0.05%38.860.2%$45.15m
LCILannett Company, Inc.
4.64%16.9037.9%$12.85m
EPIXESSA Pharma Inc
-5.07%3.370.0%$0.19m
AKTXAkari Therapeutics Plc Sponsored ADR
-7.36%1.761.7%$0.11m

Company Profile

BeyondSpring, Inc. is a clinical stage company, which engages in the development of cancer therapies. It focuses on non-small cell lung cancer, neutropenia prevention, and plinabulin and nivolumab. The company was founded by Lan Huang and Lin Qing Jia in 2013 and is headquartered in New York, NY.